| Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687) |
|---|
| 08/11/2011 | US20110195957 Substituted diazepan orexin receptor antagonists |
| 08/11/2011 | US20110195955 Highly selective sigma receptor ligands |
| 08/11/2011 | US20110195951 Diazaindole derivatives and their use in the inhibition of c-jun n-terminal kinase |
| 08/11/2011 | US20110195949 2-benzothiophenyl- and 2-naphthyl-oxazolidinones and their azaisostere analogues as antibacterial agents |
| 08/11/2011 | US20110195948 Substituted Pyrazolo[1,5-a]Pyrimidine Compounds as TRK Kinase Inhibitors |
| 08/11/2011 | US20110195933 Pyrazolo[1,5-a]pyridines as mark inhibitors |
| 08/11/2011 | US20110195932 Drug Combinations for the Treatment of Duchenne Muscular Dystrophy |
| 08/11/2011 | US20110195094 Triazole compounds that modulate hsp90 activity |
| 08/11/2011 | US20110193074 Novel compound and organic device using same |
| 08/11/2011 | DE102010007281A1 Neue Aminoalkyl-oxazol- und Aminoalkyl-thiazolcarbonsäureamide und ihre Anwendung zur Stimulation der endogenen situ Regeneration von Haarsinneszellen im Corti'schen Organ des Innenohres beim Säuger New aminoalkyl-oxazole and aminoalkyl thiazolecarboxamides and their application for the stimulation of endogenous situ regeneration of hair cells in the organ of Corti in the inner ear in mammals |
| 08/11/2011 | CA2789279A1 1,2,4-triazine-4-amine derivatives |
| 08/11/2011 | CA2789013A1 Novel aminoalkyloxazole- and aminoalkylthiazolecarboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue |
| 08/10/2011 | EP2354137A1 Urea derivatives, methods for their manufacture, and uses thereof |
| 08/10/2011 | EP2354136A1 Novel dopamine d3 receptor ligands, the preparation and use thereof |
| 08/10/2011 | EP2354128A1 Method for the preparation of rivaroxaban |
| 08/10/2011 | EP2352731A1 Gamma secretase modulators |
| 08/10/2011 | EP2352730A2 Biologically active amides |
| 08/10/2011 | EP2203431B1 Anti-infective pyrimidines and uses thereof |
| 08/10/2011 | EP2197854B1 A new class of histone deacetylase inhibitors |
| 08/10/2011 | EP2170873B1 Isoxazole-imidazole derivatives |
| 08/10/2011 | EP1841760B1 Pyrimidine derivatives as kinase modulators and method of use |
| 08/10/2011 | CN102149774A Lighting cover |
| 08/10/2011 | CN102149697A 6-substituted benzoxazines as 5-HT-5A receptor antagonists |
| 08/10/2011 | CN102149696A 含氮杂环化合物及有害生物防除剂 Containing heterocyclic compound and pest control agent |
| 08/10/2011 | CN102149680A Nitrogen-containing aromatic heterocyclyl compound |
| 08/10/2011 | CN102149678A Novel ortho-aminoanilides for the treatment of cancer |
| 08/10/2011 | CN102146056A N-benzyl-acridone, derivatives of N-benzyl-acridone and preparation methods and application of N-benzyl-acridone and derivatives |
| 08/10/2011 | CN101415702B Hetero compound |
| 08/10/2011 | CN101233128B Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes |
| 08/09/2011 | US7994331 Heterocycle-substituted benzimidazole derivative |
| 08/09/2011 | US7994204 Binding inhibitor of sphingosine-1-phosphate |
| 08/09/2011 | US7994199 Heterocyclic compounds, methods for the preparation thereof, and uses thereof |
| 08/09/2011 | US7994198 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 08/09/2011 | US7994177 Therapeutic agents useful for treating pain |
| 08/09/2011 | US7994171 Compounds for the treatment of hepatitis C |
| 08/09/2011 | US7994164 Mineralocorticoid receptor antagonists and methods of use |
| 08/09/2011 | CA2612398C Helix 12 directed non-steroidal antiandrogens |
| 08/09/2011 | CA2607359C Compounds and methods for the treatment or prevention of flavivirus infections |
| 08/09/2011 | CA2572208C 3-carbamoyl-2-pyridone derivative |
| 08/09/2011 | CA2552050C Substituted heterocycles and the uses thereof |
| 08/09/2011 | CA2542279C Bicyclic [3.1.0] derivatives as glycine transporter inhibitors |
| 08/09/2011 | CA2539707C Quinoline potassium channel inhibitors |
| 08/09/2011 | CA2520027C 2,3,6-trisubstituted-4-pyrimidone derivatives |
| 08/09/2011 | CA2487727C Compounds useful in the treatment of anthrax and inhibiting lethal factor |
| 08/09/2011 | CA2441492C Rho-kinase inhibitors |
| 08/09/2011 | CA2431083C Inflammatory cytokine release inhibitor |
| 08/04/2011 | WO2011093924A1 Bicyclic heteroaryl inhibitors of pde4 |
| 08/04/2011 | WO2011093524A1 Di - substituted pyridine derivatives as anticancers |
| 08/04/2011 | WO2011093365A1 Nitrogenated heterocyclic compound |
| 08/04/2011 | WO2011092198A1 5-alkynyl-pyrimidines |
| 08/04/2011 | WO2011092197A1 5-alkynyl pyrimidines and their use as kinase inhibitors |
| 08/04/2011 | WO2011092187A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/04/2011 | WO2011091840A2 Materials for organic electroluminescent devices |
| 08/04/2011 | WO2010127237A3 Cyclic inhibitors of 11beta-hydroxysteroid dehydrogenase 1 |
| 08/04/2011 | US20110190493 Spiroketal-Substituted Cyclic Ketoenols |
| 08/04/2011 | US20110190491 S-triazole alpha- mercaptoacetanilides as inhibitors of hiv reverse transcriptase |
| 08/04/2011 | US20110190490 Oxazolopyrimidines as edg-1 receptor agonists |
| 08/04/2011 | US20110190489 Novel Tricyclic Compounds |
| 08/04/2011 | US20110190355 Heterocyclic indazole derivatives |
| 08/04/2011 | US20110190351 Benzoimidazole Derivatives and Glycogen Synthase Kinase-3 Beta Inhibitors Containing the Same |
| 08/04/2011 | US20110190346 Diphenyl Substituted Alkanes as Flap Inhibitors |
| 08/04/2011 | US20110190314 Pharmaceutical compositions and their methods of use |
| 08/04/2011 | US20110190300 Amide compounds and the use thereof |
| 08/04/2011 | US20110190298 4-phenoxymethylpiperidines as modulators of gpr119 activity |
| 08/04/2011 | US20110190297 Pyridine and pyrimidine based compounds as wnt signaling pathway inhibitors for the treatment of cancer |
| 08/04/2011 | US20110190296 Substituted Pyrrole Derivatives and Their Use as HMG-CO Inhibitors |
| 08/04/2011 | US20110190295 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling |
| 08/04/2011 | US20110190294 Novel estrogen receptor ligands |
| 08/04/2011 | US20110190293 Quinazolinone Compounds as Anticancer Agents |
| 08/04/2011 | US20110190291 Prodrug and Fluoregenic Compositions and Methods for Using the Same |
| 08/04/2011 | US20110190290 1h-pyrazolo[3,4-b]pyridines and therapeutic uses thereof |
| 08/04/2011 | US20110190287 Thrombocyte Inhibition Via Vivo-Morpholino Knockdown of Alpha IIB |
| 08/04/2011 | US20110190286 Therapeutically active cyclopentanes |
| 08/04/2011 | US20110190282 Novel vegf-2 receptor and protein tyrosine kinase inhibitors and pharmaceutical use thereof |
| 08/04/2011 | US20110190281 Sulfone substituted 2,3-dihydroimidazo [1,2-c] quinazoline derivatives useful for treating hyper-proliferative disorders and diseases with angiogenesis |
| 08/04/2011 | US20110190280 Thiazole And Oxazole Kinase Inhibitors |
| 08/04/2011 | US20110190278 Bicyclic heterocyclic derivative |
| 08/04/2011 | US20110190272 Chemical compounds |
| 08/04/2011 | US20110190266 5,6,6a,7,8,9-HEXAHYDRO-2H-PYRIDOPHTHALAZINONE INHIBITORS OF POLY(ADP-RIBOSE)POLYMERASE (PARP) |
| 08/04/2011 | US20110190264 Compounds and compositions as kinase inhibitors |
| 08/04/2011 | US20110190262 Aryl-and Heteroarylcarbonyl derivatives of benzomorphanes and related scaffolds, medicaments containing such compounds and their use |
| 08/04/2011 | US20110190259 Compounds and compositions as protein kinase inhibitors |
| 08/04/2011 | US20110190256 Amine and Ether Compounds Which Modulate The CB2 Receptor |
| 08/04/2011 | US20110190255 Heterocyclic compounds |
| 08/04/2011 | US20110190247 Cyclopropylchromene derivatives as modulators of the alpha-2c receptor |
| 08/04/2011 | US20110190205 Compounds, Methods and Formulations for the Oral Delivery of a Glucagon-Like Peptide (Glp)-1 Compound or a Melanocortin-4 Receptor (Mc4) Agonist Peptide |
| 08/04/2011 | DE102009041241A1 New heteroaromatic compounds are hypoxia-inducible factor inhibitors useful to treat and/or prevent e.g. cancer or tumor diseases, heart attack, arrhythmia, stroke, psoriasis, diabetic retinopathy, rheumatoid arthritis and polycythemia |
| 08/04/2011 | CA2788073A1 Di-substituted pyridine derivatives as anticancers |
| 08/04/2011 | CA2787407A1 5-alkynyl-pyrimidines |
| 08/04/2011 | CA2787396A1 5-alkynyl pyrimidines and their use as kinase inhibitors |
| 08/04/2011 | CA2784571A1 Oxygen-substituted 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 08/04/2011 | CA2770767A1 Bicyclic heteroaryl inhibitors of pde4 |
| 08/03/2011 | EP2351752A1 PYRIDINE DERIVATIVE HAVING SUBSTITUTED HETERO RING AND SUBSTITUTED y-GLUTAMYLAMINO GROUP, AND ANTI-FUNGAL AGENT COMPRISING SAME |
| 08/03/2011 | EP2351745A1 Pyrazine derivatives and use as PI3K inhibitors |
| 08/03/2011 | EP2351737A1 3-Amino-1-arylpropyl indoles and aza-substituted indoles |
| 08/03/2011 | EP2351565A1 Medicine for preventing or treating pain related to herpes zoster |
| 08/03/2011 | EP2350097A1 Heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 08/03/2011 | EP2350073A1 3H-IMIDAZO[4,5-b]PYRIDINE-6-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS |
| 08/03/2011 | EP2350066A1 2,5-disubstituted piperidine orexin receptor antagonists |
| 08/03/2011 | EP2350064A1 Compounds for inflammation and immune-related uses |